Healthy Aging

Through Internet Counselling

in the Elderly



Collaborative project co-funded by the European Unions' Seventh Framework Programme (FP7, 2007-2013) under grant agreement No 305374.

flag European Union   logo FP7 Cooperation

On 2 June 2016 the bi-annual General Assembly consortium meeting with representatives from each institution took place in Amsterdam. During this meeting the finalizing of the recruitment phase, the first experiences with the 12 months assessment and boost, and the final touch for the 18 months assessment were discussed. Also the first analyses on the baseline data were presented. It was also time to look ahead on building additional options into the shared data platform and further to utilizing the extensive data collection, beyond the plans that are already there. Also plans are made for future cooperation, beyond HATICE. It was a profitable day, underlining the next phase for HATICE.
Edo esocFrom May 9th till May 12th 2016 the second ESOC (European Stroke Organisation Conference) took place in Barcelona, Spain. Edo Richard presented encouraging data on the PreDIVA trial, which illustrated the effect of a multidomain intervention on cognitive functioning in general practice. With more than 3000 attendees this was a perfect opportunity to let the world know about PreDIVA. HATICE was also enthusiastically presented in the poster area with posters on the 'baseline characteristics HATICE' and 'blood pressure variability in PreDIVA'.
Hatice was well represented at the 8th Clinical Trials in Alzheimer's Disease conference in Barcelona, Spain, November 5-7, 2015. For more information see alzforum.org.
The teams in Finland, France and the Netherlands are working very hard on including participants in the HATICE trial. In the Netherlands and Finland the first participants have been included in HATICE over 12 months ago, which means the 12 month assessments have started.

An ancillary study on determinants of participation (ACCEPT-HATICE) will start very soon. Individuals who are invited to take part in the HATICE trial and are eligible to do so will be asked to fill in a short self-administered questionnaire in order to study determinants of participation as well as barriers and facilitators to participation. This sub-study is called the ACCEPT-HATICE study. The questionnaire will include questions about socio-demographics, psychosocial characteristics (e.g. social support network), perceived health, and reasons for participation or non participation. Both persons who accept to participate in the trial and people who do not wish to participate will be asked to fill out these questionnaires. Furthermore, individual semi-structured interviews and/or focus groups will also be conducted with a subsample of HATICE participants and non participants (N=30/country) to further explore reasons for participation/non participation at baseline, and facilitators and barriers to adherence during the first year of follow-up.

In June 2016 the inclusion of participants in the HATICE trial is expected to be complete. Scientific progress will be communicated via this website.

29 March 2016

From October 21st to October 25th 2015 the WONCA (World Organization of Family Doctors) Europe conference took place in Istanbul. In this large event, over 3,500 general practitioners from Europe and beyond gathered to exchange scientific, clinical and organizational knowledge. Three HATICE PhD students from the Netherlands attended the conference. Susan Jongstra presented the protocol of the HATICE-trial and Cathrien Beishuizen presented the results of a meta-analysis on internet-interventions for older people. Throughout the conference, there was considerable attention for cardiovascular prevention, risk management and eHealth.

A good environment to promote HATICE!